Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Immunic | IMUX | 1. avr 2025 | 1.06 | -2.29 |
ImmunityBio | IBRX | 1. avr 2025 | 2.96 | -1.66 |
Immunocore ADR | IMCR | 1. avr 2025 | 28.63 | -3.51 |
Immunome | IMNM | 1. avr 2025 | 6.26 | -6.98 |
ImmunoPrecise Antibodies | IPA | 1. avr 2025 | 0.36 | -4.25 |
Immunovant | IMVT | 1. avr 2025 | 15.20 | -11.06 |
Immutep ADR | IMMP | 1. avr 2025 | 1.77 | +0.57 |
Imperial Oil | IMO | 1. avr 2025 | 72.89 | +0.79 |
Imperial Petroleum | IMPP | 1. avr 2025 | 2.45 | -0.08 |
Imperial Petroleum A Pref | IMPPP | 1. avr 2025 | 24.73 | -0.42 |
Impinj | PI | 1. avr 2025 | 88.40 | -2.54 |
Imunon | IMNN | 1. avr 2025 | 1.05 | +0.48 |
IN8bio | INAB | 1. avr 2025 | 0.17 | +4.04 |
Incannex Healthcare ADR | IXHL | 1. avr 2025 | 0.68 | +0.52 |
Income Opportunity Realty Investors | IOR | 1. avr 2025 | 17.50 | 0.00 |
Incyte | INCY | 1. avr 2025 | 60.91 | +0.59 |
Indaptus Therapeutics | INDP | 1. avr 2025 | 0.52 | -6.35 |
Independence Realty Trust | IRT | 1. avr 2025 | 21.36 | +0.61 |
Independent Bank | IBCP | 1. avr 2025 | 30.85 | +0.19 |
Independent Bank | INDB | 1. avr 2025 | 62.48 | -0.27 |
India Bull 3X Direxion | INDL | 1. avr 2025 | 54.68 | -1.60 |
India Consumer Egshares | INCO | 1. avr 2025 | 59.62 | +0.15 |
India Earnings Wisdomtree | EPI | 1. avr 2025 | 43.50 | -0.48 |
India Fund | IFN | 1. avr 2025 | 15.60 | -1.08 |
India Powershares | PIN | 1. avr 2025 | 24.87 | -0.56 |
Indie Semiconductor A | INDI | 1. avr 2025 | 1.98 | -2.70 |
Indivior | INDV | 1. avr 2025 | 9.38 | -1.57 |
Indonesia Energy | INDO | 1. avr 2025 | 2.82 | +1.81 |
Indonesia Index ETF Market Vectors | IDX | 1. avr 2025 | 12.54 | +0.40 |
Indonesia Invstble Mkt Idx MSCI Ishares | EIDO | 1. avr 2025 | 16.25 | -0.31 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.